Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of AQW051 in Patients With Memory Impairment
This study has been terminated.
Study NCT00582855   Information provided by Novartis
First Received: December 21, 2007   Last Updated: June 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mild Alzheimer's Disease
Amnestic Mild Cognitive Impairment
Additional conditions recognized in this trial
Alzheimer Disease
Cognition Disorders
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tauopathies
Interventions listed in this trial
AQW051
Placebo
Sponsors listed in this trial
Novartis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services